Table 4. GO terms with ConsensusPathDB (category BP level 4) (adjusted P<0.02).
| GO term | Set size | Candidates contained | P value | Adj. P (FDR) | |
|---|---|---|---|---|---|
| GO:0090304 | Nucleic acid metabolic process | 5,174 | 24 (0.5%) | <0.001 | 0.005 |
| GO:0034645 | Cellular macromolecule biosynthetic process | 4,867 | 23 (0.5%) | <0.001 | 0.005 |
| GO:0009889 | Regulation of biosynthetic process | 4,246 | 21 (0.5%) | <0.001 | 0.005 |
| GO:0009059 | Macromolecule biosynthetic process | 5,010 | 23 (0.5%) | <0.001 | 0.005 |
| GO:0044271 | Cellular nitrogen compound biosynthetic process | 4,906 | 22 (0.5%) | <0.001 | 0.009 |
| GO:0072359 | Circulatory system development | 1,033 | 9 (0.9%) | <0.001 | 0.011 |
| GO:0010467 | Gene expression | 5,440 | 23 (0.4%) | <0.001 | 0.011 |
| GO:0043902 | Positive regulation of multi-organism process | 161 | 4 (2.5%) | <0.001 | 0.011 |
| GO:0006338 | Chromatin remodeling | 167 | 4 (2.4%) | <0.001 | 0.011 |
| GO:0051851 | Modification by host of symbiont morphology or physiology | 75 | 3 (4.0%) | <0.001 | 0.011 |
| GO:0016569 | Covalent chromatin modification | 480 | 6 (1.2%) | <0.001 | 0.011 |
| GO:0044772 | Mitotic cell cycle phase transition | 495 | 6 (1.2%) | <0.001 | 0.012 |
| GO:0034654 | Nucleobase-containing compound biosynthetic process | 4,222 | 19 (0.5%) | <0.001 | 0.013 |
| GO:0016032 | Viral process | 721 | 7 (1.0%) | <0.001 | 0.013 |
| GO:0018130 | Heterocycle biosynthetic process | 4,285 | 19 (0.4%) | 0.001 | 0.013 |
| GO:0019438 | Aromatic compound biosynthetic process | 4,296 | 19 (0.4%) | 0.001 | 0.013 |
| GO:0043903 | Regulation of symbiosis, encompassing mutualism through parasitism | 206 | 4 (1.9%) | 0.001 | 0.013 |
| GO:0051276 | Chromosome organization | 1,211 | 9 (0.7%) | 0.001 | 0.013 |
| GO:0051171 | Regulation of nitrogen compound metabolic process | 5,904 | 23 (0.4%) | 0.001 | 0.014 |
| GO:1901362 | Organic cyclic compound biosynthetic process | 4,434 | 19 (0.4%) | 0.002 | 0.016 |
| GO:0044774 | Mitotic DNA integrity checkpoint | 106 | 3 (2.8%) | 0.002 | 0.016 |
| GO:0051817 | Modification of morphology or physiology of other organism involved in symbiotic interaction | 111 | 3 (2.7%) | 0.002 | 0.017 |
| GO:0080090 | Regulation of primary metabolic process | 6,071 | 23 (0.4%) | 0.002 | 0.018 |
| GO:0044843 | Cell cycle G1/S phase transition | 252 | 4 (1.6%) | 0.002 | 0.018 |
| GO:0071826 | Ribonucleoprotein complex subunit organization | 253 | 4 (1.6%) | 0.002 | 0.018 |
| GO:0031323 | Regulation of cellular metabolic process | 6,130 | 23 (0.4%) | 0.002 | 0.018 |
| GO:0006974 | Cellular response to DNA damage stimulus | 850 | 7 (0.8%) | 0.003 | 0.018 |
| GO:0060255 | Regulation of macromolecule metabolic process | 6,156 | 23 (0.4%) | 0.003 | 0.018 |
| GO:0051101 | Regulation of DNA binding | 127 | 3 (2.4%) | 0.003 | 0.019 |
GO: gene ontology, BP: blood pressure, FDR: false discovery rate.